Clinical Validity of 16α-[18F]Fluoro-17β-Estradiol Positron Emission Tomography/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer.
Saved in:
| Title: | Clinical Validity of 16α-[18F]Fluoro-17β-Estradiol Positron Emission Tomography/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer. |
|---|---|
| Authors: | van Geel JJL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Boers J; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Glaudemans AWJM; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Vries EFJ; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., van Kruchten M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kuip EJM; Department of Medical Oncology, Radboud Medical Center, Nijmegen, the Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Menke-van der Houven van Oordt WC; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, the Netherlands., van der Vegt B; Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Schröder CP; Department of Medical Oncology, Dutch Cancer Institute, Amsterdam and University Medical Center Groningen, Groningen, the Netherlands. |
| Corporate Authors: | IMPACT-Metastatic Breast Consortium |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Nov 01; Vol. 40 (31), pp. 3642-3652. Date of Electronic Publication: 2022 May 18. |
| Publication Type: | Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
